Agios Reports Business Highlights and First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
Agios Pharma (AGIO) Tops Q1 EPS by 7c
May 5, 2022 7:13 AM EDTAgios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.74), $0.07 better than the analyst estimate of ($1.81). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $2.75 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More